There are 700 resources available
Invited discussant abstracts 1O, 2O and 3O
Presenter: Chiara Cremolini
Session: Proffered Paper session
Resources:
Slides
Webcast
Q&A and discussion
Session: Proffered Paper session
Resources:
Webcast
LBA3 - Final analysis of the phase III KEYNOTE-585 study of pembrolizumab plus chemotherapy vs chemotherapy as perioperative therapy in locally-advanced gastric and gastroesophageal junction cancer
Presenter: Kohei Shitara
Session: Proffered Paper session
Resources:
Abstract
Slides
Webcast
LBA4 - Switch maintenance with ramucirumab plus paclitaxel versus continuation of oxaliplatin-based chemotherapy in advanced HER2-negative gastric or gastroesophageal junction (GEJ) cancer: Final results and key biomarkers of the ARMANI phase III trial
Presenter: Giovanni Randon
Session: Proffered Paper session
Resources:
Abstract
Invited discussant LBA3 and LBA4
Presenter: Elizabeth Smyth
Session: Proffered Paper session
Resources:
Slides
Webcast
Q&A and discussion
Session: Proffered Paper session
Resources:
Webcast
9P - Positive ad hoc results from neoadjuvant Foxy-5 treatment of colon cancer patients in the ongoing phase II NeoFox study
Presenter: Ramon Salazar
Session: Poster Display session
10P - A placebo-controlled study comparing doses and efficacy of lentinula edodes mycelia for chemotherapy-induced peripheral neuropathy in colorectal cancer: The LEMON trial
Presenter: Hironaga Satake
Session: Poster Display session
11P - Prophylactic hyperthermic intraperitoneal chemotherapy for colon cancer patients at high risk of peritoneal metastases: An individual patient data meta-analysis
Presenter: Julie Hamm
Session: Poster Display session
12P - The prognostic significance of BRAF mutations in early-stage colon cancer
Presenter: Laurie-Rose Dubé
Session: Poster Display session